Wind River Selected by BAE Systems for Team Tempest Advanced Combat Air Systems Development
26.4.2022 13:00:00 EEST | Business Wire | Press release
Wind River®, a global leader in delivering software for intelligent systems, today announced it has been selected by BAE Systems to support technology demonstration work as part of the Tempest future combat air system program.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220426005579/en/
Tempest. Credit: BAE Systems
“We are honored be working with BAE Systems,” said Avijit Sinha, chief product officer, Wind River. “The selection of our industry-leading technology demonstrates continuing Wind River leadership in safety-critical real-time software solutions for avionics.”
Wind River software is in use by more than 360 customers over 600 safety programs in more than 100 civilian, military, and space systems, delivering innovative technology that solves real business problems.
BAE Systems will be using the VxWorks 653 platform, a part of Wind River Studio, and associated DO-178C DAL B safety certification evidence packages, and AdaCore GNAT Pro Assurance as part of ongoing technology demonstration project work in support of the program. Wind River Studio is a cloud-native platform for the development, deployment, operations, and servicing of mission-critical intelligent systems.
The aerospace and defense market has high urgency to build the most complete intelligent systems, according to recent research. True compute on the far edge and the ability to emulate and simulate in real time are two of the most important intelligent systems characteristics for future success. In this industry, the ability to make accurate, quick decisions in high-risk scenarios is critical, and artificial intelligence is becoming an increasingly important investment.1
Team Tempest is a co-funded technology initiative launched by the Royal Air Force Rapid Capabilities Office and U.K. industry partners with the aim of advancing combat air technology. BAE Systems is one of the founding members of Team Tempest.
The Tempest future combat air system will incorporate advanced technical capabilities including AI, which creates opportunities such as the ability to fly manned or unmanned or to use swarming technology to control drones. Tempest is currently in the concept and assessment phase. Initial operating capability is expected in the mid-2030s.
Leveraging a safety-critical platform with COTS safety certification packages can reduce technical program risk. Proven in the most challenging safety-critical applications, VxWorks 653 makes it easier and more cost-effective for technology suppliers to meet the stringent safety certification requirements of EN 50128, IEC 61508, ISO 26262, DO-178C, and ED-12C.
About Wind River
Wind River is a global leader in delivering software for intelligent systems. The company’s technology has been powering the safest, most secure devices in the world since 1981 and is found in billions of products. Wind River offers a comprehensive portfolio, supported by world-class global professional services and support and a broad partner ecosystem. Wind River software and expertise are accelerating digital transformation of mission-critical intelligent systems that will increasingly demand greater compute and AI capabilities while delivering the highest levels of security, safety, and reliability. To learn more, visit Wind River at www.windriver.com.
1 Forbes/Wind River, “Characteristics of Intelligent Systems,” 2021
Wind River is a trademark or registered trademark of Wind River Systems, Inc., and its affiliates. Other names may be the trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220426005579/en/
Contact information
MEDIA CONTACT
Jenny Suh
Wind River
510-749-2972
jenny.suh@windriver.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 11:22:00 EET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom